冠動脈全閉塞治療の定義と臨床試験設計原則:CTO-ARCコンセンサス勧告
Luiz F Ybarra1, Stéphane Rinfret2, Emmanouil S Brilakis3
1London Health Sciences Centre, Schulich School of Medicine and Dentistry, Western University, Ontario, Canada (L.F.Y.).
Circulation
|February 1, 2021
まとめ
慢性完全閉塞 (CTO) 経皮冠動脈介入の標準化には,一貫した方法と定義が必要です. 慢性完全閉塞学術研究コンソーシアムは,この心臓病サブスペシャリティの臨床試験データを改善することを目的としています.
科学分野:
- 介入心臓科
- 心血管研究
背景:
- 慢性完全閉塞 (CTO) 経皮冠動脈干渉 (PCI) は著しく進展しました.
- 限られたランダム化試験と矛盾する観察データは,安全性と有効性の評価を妨げています.
- 標準化されたエンドポイントと定義の欠如は,CTOの介入結果の一貫した解釈を妨げています.
関連する概念動画
Coronary Artery Disease V: Interprofessional Care
124
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
124
Acute Coronary Syndrome III: Diagnostic Studies
92
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
92
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
133
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
133
Atherosclerosis III: Management
114
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
114
Peripheral Artery Disease III: Interprofessional Care
114
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
114
Coronary Artery Disease III: Clinical Manifestations
149
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
149


